Sonali Smith, MD
Enriched profileElwood V. Jensen Professor of Medicine and Section Chief of Hematology/Oncology, UChicago Medicine · University of Chicago
Sonali Smith is Elwood V. Jensen Professor of Medicine and Section Chief of Hematology/Oncology, UChicago Medicine at University of Chicago. OpenAlex indexes 522 publications with 17,150 citations (h-index 62); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 23 Oct 2026
Overview
Updated 24 Oct 2026
Sonali Smith is Elwood V. Jensen Professor of Medicine and Section Chief of Hematology/Oncology, UChicago Medicine at University of Chicago. The public record shows 522 publications with 17,150 citations (h-index 62), centered on Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 7 companies, 1 NIH-funded awards (2020–2024).
- Most recent indexed publication: 2026 · Blood advances
- Top research focus: Lymphoma Diagnosis and Treatment
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 25 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 204.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 24 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma
Sponsor: University of Chicago
- Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
Sponsor: University of Chicago
- Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Sponsor: Alliance for Clinical Trials in Oncology
Industry payments
Updated 24 Oct 2026
7 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20245 payments
- Genmab U.S., Inc.Program year20242 payments
- AbbVie Inc.Program year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
57.2%Kinase inhibitor57.2%Brukinsa56%Calquence29%Jaypirca15%Part D<11 patientsDermatology
26%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor26%Acyclovir100%Part D≥16 patientsAnti-infectives
10%Short-acting sulfonamides10%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 24 Oct 2026
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
Congress activity
Updated 24 Oct 2026
92 congress contributions (2004–2025) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Outcomes of autologous transplant (ASCT) in patients with chemosensitive late relapse of large B-cell lymphoma (LBCL)
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 24 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop.
Blood advances
Review2026 - A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.
Blood advances
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01
- 02CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s LymphomaArticle1,129 citations2018
- 03
- 04
- 05Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaArticle488 citations2011
Network
Updated 24 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 24 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/sonali-smith-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
biologicalsciences.uchicago.edu/faculty/sonali-smith
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biologicalsciences.uchicago.edu ↗ - Other
profiles.uchicago.edu/profiles/profile/38199
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.uchicago.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 24 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗
- MD
Northwestern University medical school (per profile)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Hematology/oncology fellowship
University of Chicago
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗
- Vice-Chair
SWOG Lymphoma Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗ - Immediate past-Chair
Scientific Advisory Board, Lymphoma Research Foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗ - Past Chair
ASCO Communications Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗ - Fellow
American Society of Clinical Oncology (FASCO)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →education.binayfoundation.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →education.binayfoundation.org ↗
- Lead
ASCO Women's Networking Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Co-Director of the Lymphoma Program
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Mary Rinella, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
Seth Steinberg, PhD
National Cancer Institute (NCI)
Gilles Salles
Memorial Sloan Kettering Cancer Center
Thomas Witzig, MD
Mayo Clinic
Wyndham Wilson, MD
National Cancer Institute (NCI)